Asset allocation
Distribution
| Type | % Net assets | % Short | % Long |
|---|---|---|---|
| US stock | 99.95% | 0.00% | 99.95% |
| Cash | 0.05% | 0.00% | 0.05% |
| Non-US stock | 0.00% | 0.00% | 0.00% |
| US bond | 0.00% | 0.00% | 0.00% |
| Non-US bond | 0.00% | 0.00% | 0.00% |
| Other | 0.00% | 0.00% | 0.00% |
As of May 31 2025
Weightings
Sectors
- Sectors
- Regions
| Sector | % Net assets | Category average |
|---|---|---|
| Healthcare | 99.95% | 97.32% |
| Other | 0.00% | 2.51% |
| Real Estate | 0.00% | 0.13% |
| Consumer Defensive | 0.00% | 0.04% |
As of May 31 2025. Sectors weighting is calculated using only long position holdings of the portfolio.
Top 10 holdings
| Top 10 holdings as a per cent of portfolio | |||
|---|---|---|---|
| 46.35% | 54.94% | 0.00% | 54.94% |
| Category average | % Net assets | % Short | % Long |
| Company | 1 year change | Portfolio weight | Long allocation |
|---|---|---|---|
| Eli Lilly and Co LLY:NYQ | -13.90% | 12.06% | |
| Johnson & Johnson JNJ:NYQ | +4.51% | 7.75% | |
| AbbVie Inc ABBV:NYQ | +8.22% | 6.81% | |
| UnitedHealth Group Inc UNH:NYQ | -38.74% | 5.76% | |
| Abbott Laboratories ABT:NYQ | +30.89% | 4.81% | |
| Intuitive Surgical Inc ISRG:NSQ | +22.16% | 4.09% | |
| Merck & Co Inc MRK:NYQ | -36.06% | 4.03% | |
| Boston Scientific Corp BSX:NYQ | +39.48% | 3.22% | |
| Amgen Inc AMGN:NSQ | -10.64% | 3.21% | |
| Thermo Fisher Scientific Inc TMO:NYQ | -26.68% | 3.20% | |
| Per cent of portfolio in top 10 holdings: 54.94% |
